Registered entities
Ikena Oncology, Inc.
Reg. No. 811697316United States
Ikena Oncology, Inc.
Reg. No. 81-1697316United States
Innovation
40 patent families (7 granted) — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 3,093 times.
| Year | Filings |
|---|---|
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 12 |
| 2022 | 26 |
| 2023 | 19 |
| 2024 | 16 |
| 2025 | 4 |
| 2026 | 1 |
Investor mix
12 investors on record; lead investors include Omega Funds.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 3 | 25% |
| Private equity | 2 | 17% |
| Bank & private debt | 3 | 25% |
| Other / undisclosed | 4 | 33% |